Literature DB >> 549550

[Silymarin in pregnancy and during hormonal contraceptive treatment. Blood chemistry and ultrastructural findings in the experimental model].

G Martines, M Piva, V Copponi, G Cagnetta.   

Abstract

Further systematic study of the relation between drugs and the ultrastructure of the liver is reported with regard to the experimental administration of silimarin to pregnant women and others on the pill. Marked signs of ultrastructural alteration of the REL and biliary cell pole were noted, matched, by evidence of throbophilia and changes in protein activity and lipid synthesis, are noted in these situations, but not when suitable doses of silimarine are taken with the pill. It is suggested that silimarin may prevent and correct liver damage during pregnancy and the administration of oestroprogestins.

Entities:  

Keywords:  Animals, Laboratory; Biology; Clinical Research; Contraception; Contraceptive Methods--side effects; Diseases; Family Planning; Hepatic Effects; Oral Contraceptives--side effects; Physiology; Pregnancy; Pregnancy Complications; Research Methodology

Mesh:

Substances:

Year:  1979        PMID: 549550

Source DB:  PubMed          Journal:  Arch Sci Med (Torino)        ISSN: 0004-0312


  3 in total

1.  Effects of silybum marianum on patients with chronic hepatitis C.

Authors:  Hamid Kalantari; Zahra Shahshahan; Sayed Mehdi Hejazi; Taghi Ghafghazi; Vahid Sebghatolahi
Journal:  J Res Med Sci       Date:  2011-03       Impact factor: 1.852

2.  The impact of Silymarin on improvement of platelet abnormalities in patients with severe preeclampsia.

Authors:  Fahimeh Kaveh Baghbahadorani; Sepideh Miraj
Journal:  Electron Physician       Date:  2016-05-25

3.  The Impact of Silymarin on Improvement of Hepatic Abnormalities in Patients with Severe Preeclampsia: A Randomized Clinical Trial.

Authors:  Fahimeh Kaveh Baghbahadorani; Sepideh Miraj
Journal:  Electron Physician       Date:  2017-08-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.